Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase

Blood

Volumn 93, Issue 8, 1999, Pages 2578-2585

  Lecoq Lafon, Carinne ^b   Verdier, Frédérique ^b   Fichelson, Serge ^b   Chrétien, Stany ^b   Gisselbrecht, Sylvie ^b   Lacombe, Catherine ^b   Mayeux, Patrick ^a  

^a Université Paris Descartes   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL STIMULATION; COLONY FORMATION; DIMERIZATION; DOSE RESPONSE; ENZYME ACTIVATION; ERYTHROPOIESIS; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; STEM CELL;

EID: 0033560812     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.8.2578.408k24_2578_2585     Document Type: Article

References (38)

1. Wu H, Liu X, Jaenish R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59, 1995
2. D'Andrea AD, Lodish HF, Wong GG: Expression cloning of the murine erythropoietin receptor. Cell 57:277, 1989
3. Socolovsky M, Lodish HF, Daley GQ: Control of hematopoietic differentiation: Lack of specificity in signaling by cytokine receptors. Proc Natl Acad Sci USA 95:6573, 1998
4. Witthuhn B, Quelle FW, Silvennoinen O, Yi T, Tang B, Muira O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following Epo stimulation. Cell 74:227, 1993
5. Damen J, Mui ALF, Hughes P, Humphries KR, Krystal G: Erythropoietin-induced tyrosine phosphorylation in a high erythropoietin-receptor expressing lymphoid cell line. Blood 80:1923, 1992
6. Dusanter-Fourt I, Casadevall N, Lacombe C, Muller O, Billat C, Fischer S, Mayeux P: Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J Biol Chem 267:10670, 1992
7. Miura O, D'Andrea A, Kabat D, Ihle JN: Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis. Mol Cell Biol 11:4895, 1991
8. Yoshimura A, Lodish HF: In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130. Mol Cell Biol 12:706, 1992
9. Damen JE, Krystal G: Early events in erythropoietin-induced signaling. Exp Hematol 24:1455, 1996
10. Damen JE, Mui ALF, Puil L, Pawson T, Krystal G: Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81:3204, 1993
11. Mayeux P, Dusanter-Fourt I, Muller O, Mauduit P, Sabbah M, Drucker B, Vainchencker W, Fischer S, Lacombe C, Gisselbrecht S: Erythropoietin induces the association of phosphatidylinositol 3′ kinase with a tyrosine phosphorylated complex containing the erythropoietin receptor. Eur J Biochem 216:821, 1993
12. He TC, Zhuang H, Jiang N, Waterfield MD, Wojchowski DM: Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood 82:3530, 1993
13. Miura O, Nakamura N, Ihle JN, Aoki N: Erythropoietin-dependent Association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J Biol Chem 269:614, 1994
14. Damen J, Cutler RL, Jiao H, Yi T, Krystal G: Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the p85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J Biol Chem 270:23402, 1995
15. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B, Cantley LC: SH2 domains recognize specific phosphopeptide sequences. Cell 72:767, 1993
16. Gobert S, Porteu F, Pallu S, Muller O, Sabbah M, Dusanter-Fourt I, Courtois G, Lacombe C, Gisselbrecht S, Mayeux P: Tyrosine phosphorylation of the erythropoietin receptor: Role for differentiation and mitogenic signal transduction. Blood 86:598, 1995
17. Shigematsu H, Iwasaki H, Otsuka T, Ohno Y, Arima F, Niho Y: Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J Biol Chem 272:14334, 1997
18. Verdier F, Chrétien S, Billat C, Gisselbrecht S, Lacombe C, Mayeux P: Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2: An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation. J Biol Chem 272: 26173, 1997
19. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ: A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379:560, 1996
20. Bardelli A, Longati P, Gramaglia D, Stella MC, Comoglio PM: Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential. Oncogene 15:3103, 1997
21. Fixman ED, Holgado-Madruga M, Nguyen L, Kamikura DM, Fournier TM, Wong AJ, Park M: Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cb1 and Gab1. J Biol Chem 272:20167, 1997
22. Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J, Birchmeier W: Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384:173, 1996
23. Nguyen L, Holgado-Madruga M, Maroun C, Fixman ED, Kamikura D, Fournier T, Charest A, Tremblay ML, Wong AJ, Park M: Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J Biol Chem 272:20811, 1997
24. Takahashi-Tezuka M, Yoshida Y, Fukada T, Ohtani T, Yamanaka Y, Nishida K, Nakajima K, Hibi M, Hirano T: Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol Cell Biol 18:4109, 1998
25. Holgado-Madruga M, Moscatello DK, Emlet DR, Dieterich R, Wong AJ: Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc Natl Acad Sci USA 94:12419, 1997
26. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yamata Y, Suda T, Miura Y: Establishment and characterization of a human leukemic cell line with megakaryocytic features: Dependency on granulocyte-macrophage colony stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 51:341, 1991
27. Porteu F, Rouyez MC, Cocault L, Benit L, Charon M, Picard F, Gisselbrecht S, Souyri M, Dusanter-Fourt I: Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: Evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin. Mol Cell Biol 16:2473, 1996
28. Kapeller R, Cantley LC: Phosphatidylinositol 3-kinase. Bioessays 16:565, 1994
29. Hermine O, Mayeux P, Titeux M, Mitjavila MT, Casadevall N, Guichard J, Komatsu N, Suda T, Miura Y, Vainchenker W, Breton-Gorius J: Granulocyte-macrophage colony-stimulating factor and erythropoietin act competitively to induce two different programs of differentiation in the human pluripotent cell line UT-7. Blood 80:3060, 1992
30. Franke TF, Kaplan DR, Cantley LC: PI3K: Downstream AKTion blocks apoptosis. Cell 88:435, 1997
31. Rordorf-Nikolic T, van Horn DJ, Chen D, White MF, Backer JM: Regulation of phosphatidylinositol 3′-kinaseby tyrosyl phosphoproteins: Full activation requires occupancy of both SH2 domains in the 85 kDa regulatory subunit. J Biol Chem 270:3662, 1995
32. Rocchi S, Tartare-Deckert S, Murdaca J, Holgado-Madruga M, Wong AJ, Van Obberghen E: Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules. Mol Endocrinol 12:914, 1998
33. Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK: Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12:1610, 1998
34. Franke TF, Kaplan DR, Cantley LC, Toker A: Direct regulation of the AKT proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:685, 1997
35. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231, 1997
36. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687, 1997
37. Klingmuller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC, Lodish HF: Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci USA 94:3016, 1997
38. De La Chapelle A, Traskelin A, Juvonen E: Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 90:4495, 1993